News

Lionsgate Partners with FreeWheel for Enhanced Streaming Ads

Lionsgate Partners with FreeWheel for Enhanced Streaming Ads

Lionsgate Studios Partners with FreeWheel

Lionsgate Studios Corp. (NYSE: LION) has recently taken significant steps to enhance its streaming services by entering a partnership with FreeWheel. This collaboration is set to revolutionize how advertisers engage with Lionsgate’s content, as it expands the company’s ad-supported streaming options significantly.

Enhanced Access to Ad Inventory

This innovative partnership allows advertisers greater access to Lionsgate’s extensive catalog of streaming content. Through FreeWheel’s supply-side platform, advertisers can now seamlessly purchase ad placements across various U.S.-based FAST channels.

Streamlined Advertising Process

The new system introduced by Lionsgate simplifies the process for media buyers, enabling them to reach their target audience through direct or programmatic transactions. This means advertisers can now effectively plan and execute their campaigns across nearly 30 channels with ease.

The Significance of FreeWheel Partnership

By working exclusively with FreeWheel, Lionsgate aims to improve demand management and foster revenue growth. This strategic decision supports the company’s goal of maximizing its ad-supported streaming services amidst a competitive landscape.

Two Approaches for Advertisers

Advertisers will benefit from two main approaches to purchasing ad placements: one-to-one deals and programmatic campaigns. This flexibility in advertising strategy empowers media buyers to choose the best approach that suits their needs.

The Rise of FAST Viewing

FreeWheel has noted a notable increase in interest in free ad-supported streaming television (FAST). This approach not only entertains viewers but also provides advertisers with access to a demographic that expands their reach beyond traditional television.

Changing Budgets for Advertisers

Market trends indicate that many advertisers are planning to shift their budgets towards FAST formats. Lionsgate is strategically focusing its efforts on scaling its ad-supported streaming channels to capture this new wave of advertising interest.

Content Strategies for Streaming

At present, Lionsgate operates more than 40 FAST channels globally, utilizing content from its extensive film and television library. This approach allows the company to leverage beloved titles and popular franchises to retain viewer interest.

Diverse Range of Titles

The company’s lineup includes iconic franchises such as John Wick, The Hunger Games, Twilight, and many more. With offerings that cater to a wide audience, Lionsgate is well-positioned to engage various viewer demographics.

Unified Advertising Decision Making

The collaboration with FreeWheel aims to enhance unified advertising decision-making across all branded FAST channels. This strategic measure improves yield and fosters greater efficiency for advertisers.

Advanced Targeting Tools

The access to advanced targeting tools will enable programmatic buyers to effectively reach their desired audiences. Moreover, the collaboration ensures that Lionsgate’s inventory adheres to transparent supply paths and employs premium video formats.

Words from the Executives

Chase Brisbin, Lionsgate's Executive Vice President of International SVOD Sales, emphasized the straightforward nature of choosing FreeWheel as a partner. He stated, “It was an easy decision to choose FreeWheel, a leader in the space, as our exclusive technology partner across our ad-supported FAST business.”

Strengthening Access for Advertisers

Greg Bel, FreeWheel's Vice President of Supply, expressed excitement about the partnership, highlighting its potential to strengthen advertising access for various brands. The partnership sets a hopeful tone for increased collaboration and shared growth.

Recent Stock Performance

Lionsgate Studios recently reached a trading price of $8.63, reflecting a 1.95% increase. This upward trend in share price aligns with the company’s strategic initiatives and expansion in advertising capabilities.

Frequently Asked Questions

1. What is the main goal of the partnership between Lionsgate and FreeWheel?

The primary goal is to simplify access to ad-supported streaming inventory for advertisers and enhance overall revenue growth.

2. How many FAST channels does Lionsgate operate?

Lionsgate currently operates more than 40 FAST channels globally.

3. What benefits do advertisers gain from this partnership?

Advertisers can access diverse channels through direct or programmatic transactions, allowing greater flexibility in their ad placements.

4. What popular franchises does Lionsgate feature in its content lineup?

Lionsgate features notable franchises including John Wick, The Hunger Games, and Twilight among others.

5. How does this partnership impact Lionsgate's stock performance?

The partnership has positively affected Lionsgate's stock performance, as indicated by a recent increase in share price to $8.63.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 11

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Secures $300 Million Loan for Growth

Updated Category News Views 255

America's Car-Mart Secures Funding for Future Growth America's Car-Mart, Inc. (NASDAQ: CRMT), a leading automotive retailer, has taken a strategic step by closing a significant five-year, $300 million term loan. This loan, managed by the seasoned professionals at Silver Point Capital, L.P., aims to enhance the company’s capital structure and support its long-term growth...

Continue Reading
IASO Bio's Breakthrough Drug Application Acceptance in Singapore

Updated Category News Views 251

IASO Bio’s Major Step Forward with New Drug Application IASO Biotherapeutics, a pioneering biopharmaceutical company dedicated to the advancement of innovative cell therapies and biologics, has reached a significant milestone. The Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel, known as...

Continue Reading
Creating Community Leaders: National Heritage Academies and United Way

Updated Category News Views 150

Empowering Students to Make a Difference The student-led organization is providing career opportunities while connecting with the community. National Heritage Academies® (NHA) is thrilled to celebrate its collaboration with United Way through the Student United Way program. This initiative equips high school students with essential tools and opportunities to enact...

Continue Reading
Future Growth of Augmented and Virtual Reality Technologies

Updated Category News Views 259

Exploring the Growth of Augmented Reality and Virtual Reality Market The global market for Augmented Reality (AR) and Virtual Reality (VR) is on the rise, with expectations of substantial growth over the next few years. Analysts estimate that this sector will expand by approximately USD 442.99 billion between 2024 and 2028. The compound annual growth rate (CAGR) for this...

Continue Reading
ImmVira Launches Innovative Exosome, Transforming Cosmetics

Updated Category News Views 407

ImmVira Leads the Way with Groundbreaking Exosome Technology In a remarkable advancement for the cosmetic industry, ImmVira Group has announced its innovative product, MVR-EX103, an engineered exosome specifically developed for treating superficial skin depressions. This development marks a pivotal moment, as it has successfully acquired the International Nomenclature...

Continue Reading